Mesoblast (MESO) EBITDA Margin (QoQ) (2014 - 2023)
Mesoblast (MESO) EBITDA Margin (QoQ) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 89,920.00 |
| Mar 31, 2023 | 49,657.00 |
| Dec 31, 2022 | -9,178.00 |
| Sep 30, 2022 | -56,268.00 |
| Jun 30, 2022 | 42,191.00 |
| Mar 31, 2022 | 47,065.00 |
| Dec 31, 2021 | -12,155.00 |
| Sep 30, 2021 | -5,505.00 |
| Jun 30, 2021 | 44,590.00 |
| Mar 31, 2021 | -19,253.00 |
| Dec 31, 2020 | 67,094.00 |
| Sep 30, 2020 | -159,320.00 |
| Jun 30, 2020 | 60,535.00 |
| Mar 31, 2020 | 53,285.00 |
| Dec 31, 2019 | -97,578.00 |
| Sep 30, 2019 | 118,410.00 |
| Jun 30, 2019 | 91,707.00 |
| Mar 31, 2019 | 15,514.00 |
| Dec 31, 2018 | -37,353.00 |
| Sep 30, 2018 | -71,956.00 |